I set out below the criteria for CEV and Underlining risk groups. I have put in bold where the same people are in both groups but there is clearly quite a bit of overlap on the others although not exactly the same. However in fairness I have noticed that it says that "
Individuals within these risk groups who are clinically extremely vulnerable are discussed separately (see above)". So the underlying risk group is acknowledged to include people are are also CEV. There is quite a bit of overlap.
I would imagine the big numbers in cat 6 not covered at last partly in cat 4 are:
- Morbid obesity (approx. 2m according to google)
- Diabetes (3.9 million per google)
- Chronic heart disease (7.4 million people living with heart and circulatory disease in the UK per google but I don't know if this is exactly the same classification)
So just those few (and there are a few more I haven't counted) is approx. 13 million. Maybe 50% will fall in groups 1 to 5 (large margin of error there obviously) but I could see group 6 might be as high as the higher estimates of 7 million.
f you think there are good clinical reasons why you should be added to the
Shielded Patient List, discuss your concerns with your GP or hospital clinician. People with the following conditions are automatically deemed clinically extremely vulnerable:
- solid organ transplant recipients
- people with specific cancers:
- people with cancer who are undergoing active chemotherapy
- people with lung cancer who are undergoing radical radiotherapy
- people with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment
- people having immunotherapy or other continuing antibody treatments for cancer
- people having other targeted cancer treatments that can affect the immune system, such as protein kinase inhibitors or PARP inhibitors
- people who have had bone marrow or stem cell transplants in the last 6 months or who are still taking immunosuppression drugs
- people with severe respiratory conditions including all cystic fibrosis, severe asthma and severe chronic obstructive pulmonary disease (COPD)
- people with rare diseases that significantly increase the risk of infections (such as severe combined immunodeficiency (SCID), homozygous sickle cell disease)
- people on immunosuppression therapies sufficient to significantly increase risk of infection
- problems with your spleen, for example splenectomy (having your spleen removed)
- adults with Down’s syndrome
- adults on dialysis or with chronic kidney disease (stage 5)
- women who are pregnant with significant heart disease, congenital or acquired
- other people who have also been classed as clinically extremely vulnerable, based on clinical judgement and an assessment of their needs. GPs and hospital clinicians have been provided with guidance to support these decisions
The Committee’s advice is to offer vaccination to those aged 65 years and over followed by those in
clinical risk groups aged 16 years and over. The main risk groups identified by the Committee are set out below. •
Chronic respiratory disease, including chronic obstructive pulmonary disease (COPD), cystic fibrosis and severe asthma • Chronic heart disease (and vascular disease) • Chronic kidney disease 8 • Chronic liver disease • Chronic neurological disease including epilepsy •
Down’s syndrome •
Severe and profound learning disability • Diabetes •
Solid organ, bone marrow and stem cell transplant recipients •
People with specific cancers • Immunosuppression due to disease or treatment • Asplenia and splenic dysfunction • Morbid obesity • Severe mental illness Other groups at higher risk, incl
